Athos Revenue and Competitors

Location

N/A

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • Athos's estimated annual revenue is currently $23.4M per year.(i)
  • Athos's estimated revenue per employee is $154,000

Employee Data

  • Athos has 152 Employees.(i)
  • Athos grew their employee count by 7% last year.

Athos's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27M17526%N/AN/A
#2
$0.2M3-70%N/AN/A
#3
$4.6M41-20%N/AN/A
#4
$7.3M60-32%$11.6MN/A
#5
$3.6M340%$11.4MN/A
#6
$5.2M46-15%N/AN/A
#7
$0.8M10N/AN/AN/A
#8
$14.1M101-13%$21.5MN/A
#9
$1.4M17N/AN/AN/A
#10
$4.4M3911%N/AN/A
Add Company

What Is Athos?

Athos was developed to give athletes and coaches unprecedented insight into what happens at the muscular level, to better understand the physical output of their training and competitive performance. We are committed to helping athletes of all levels perform at their highest potential, in and out of competition. Our mission: Build Better Athletes. Interested in joining? We're looking for highly-motivated and driven employees who help us stay on the cutting edge of creativity and innovation. Learn more about our career opportunities by checking back here or visiting our career page--> liveathos.com/careers

keywords:N/A

N/A

Total Funding

152

Number of Employees

$23.4M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Athos News

2022-04-13 - Monk Epifanios, The "Saint" Of Gastronomy: From Mount Athos To Michelin Restaurants — Gree ...

A monk on Mount Athos, however, took care to change that. Watch the video: Mount Athos cooking with the elder Epifanio | Oregano meatballs.

2022-04-06 - Biosimilar Deal Watch: Formycon/ATHOS, Fresenius ...

Biosimilar Deal Watch: Formycon/ATHOS, Fresenius/mAbxience/Ivenix, and Intas/Axantia ... It has been a busy last few weeks for biosimilar...

2022-03-30 - Formycon acquiring the biosimilar assets from ATHOS

Formycon acquiring biosimilar assets from ATHOS ... in the area of biosimilars through a long term strategic partnership with ATHOS AG.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.2M154N/AN/A
#2
$23.3M1555%$161M
#3
$23.9M155-5%N/A
#4
$24.2M157N/AN/A
#5
$3.9M157-6%$169.5M